Evaluation of endocan and endoglin levels in chronic kidney disease due to diabetes mellitus.
Conclusions: Endocan might be a more reliable marker of diabetic nephropathy development than endoglin.
PMID: 30697257 [PubMed]
Source: Archives of Medical Science - Category: General Medicine Tags: Arch Med Sci Source Type: research
More News: Biomedical Science | Chronic Kidney Disease | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Endocrinology | General Medicine | Science | Statistics | Study | Urology & Nephrology